| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,720,070.7620 | 4,307,865.4980 | 3,288,296.3440 | 2,651,757.6460 | 3,168,597.3340 |
| Cost of Revenue
|
-3,858,160.6110 | -3,464,294.6130 | -2,789,533.3500 | -2,081,010.6330 | -2,498,916.4430 |
|
Gross Profit
|
861,910.1510 | 843,570.8850 | 498,762.9940 | 570,747.0130 | 669,680.8910 |
| Selling, General and Administrative Expenses
|
-847,393.5840 | -692,524.3360 | -526,871.9200 | -483,753.9430 | -460,990.2900 |
|
Research and Development Expenses
|
-185,791.6610 | -166,452.2860 | -130,111.3590 | -150,985.7390 | -176,478.1300 |
| Depreciation, Amortization and Depletion
|
-68,337.3960 | -68,337.3960 | -85,690.8820 | -117,054.5510 | -112,835.1290 |
| Provision Expense/Write-Back
|
-5,870.5810 | -5,870.5810 | -7,632.5170 | -139,445.0170 | -25,044.3270 |
| Other Income/Expense, Operating
|
1,758.5290 | 1,366.6500 | 911.5560 | 2,968.7350 | 16,385.0380 |
|
Operating Income/Expenses
|
-1,105,634.6930 | -931,817.9490 | -749,395.1220 | -888,270.5150 | -758,962.8380 |
|
Total Operating Profit/Loss
|
-243,724.5420 | -88,247.0640 | -250,632.1280 | -317,523.5020 | -89,281.9470 |
| Total Net Finance Income/Expense
|
18,608.7180 | 20,334.0730 | 31,465.9440 | 34,068.2660 | 7,144.3380 |
| Net Investment Income
|
7,061.4170 | 5,543.8120 | 2,358.9950 | 1,426.3700 | 10,917.7360 |
|
Non-Operating Income/Expenses, Total
|
25,670.1350 | 25,877.8850 | 33,824.9390 | 35,494.6360 | 18,062.0740 |
|
Pretax Income
|
-218,054.4070 | -62,369.1790 | -216,807.1890 | -282,028.8660 | -71,219.8730 |
|
Provision for Income Tax
|
15,483.4310 | 22,983.5910 | 23,606.5500 | 10,192.8840 | 21,756.9440 |
|
Net Income from Continuing Operations
|
-202,570.9760 | -39,385.5880 | -193,200.6390 | -271,835.9820 | -49,462.9290 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-202,570.9760 | -39,385.5880 | -193,200.6390 | -271,835.9820 | -49,462.9290 |
|
Net Income after Non-Controlling/Minority Interests
|
-202,570.9760 | -39,385.5880 | -193,200.6390 | -271,835.9820 | -49,462.9290 |
|
Net Income Available to Common Stockholders
|
-202,570.9760 | -39,385.5880 | -193,200.6390 | -271,835.9820 | -49,462.9290 |
|
Diluted Net Income Available to Common Stockholders
|
-202,570.9760 | -39,385.5880 | -193,200.6390 | -271,835.9820 | -49,462.9290 |
| Basic EPS
|
-2.50 | -0.50 | -2.44 | -3.46 | -0.64 |
| Diluted EPS
|
-2.54 | -0.50 | -2.44 | -3.46 | -0.64 |
|
Basic Weighted Average Shares Outstanding
|
80,467.4630 | 79,857.3490 | 79,230.1210 | 78,408.0530 | 77,588.4610 |
|
Diluted Weighted Average Shares Outstanding
|
80,467.4630 | 79,857.3490 | 79,230.1210 | 78,408.0530 | 77,588.4610 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-236,663.1250 | -82,703.2520 | -248,273.1330 | -316,097.1320 | -78,364.2110 |
|
EBITDA
|
28,255.0440 | 28,255.0440 | -126,127.7800 | -168,032.3730 | 64,347.1980 |
|
Normalized EBITDA
|
137,876.1100 | 137,876.1100 | -75,720.7040 | -104,653.2570 | 113,610.8140 |
|
Normalized Income
|
-302,873.0490 | -11,654.1910 | -168,967.6610 | -224,176.6780 | 8,756.2570 |
|
Total Unusual Items
|
0 | 109,621.0660 | 50,407.0760 | 63,379.1160 | 49,263.6160 |
12/31/2022 - 10/19/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade